Decoding the Versatile Landscape of Autophagic Protein VMP1 in Cancer: A Comprehensive Review across Tissue Types and Regulatory Mechanisms

• Published in: International journal of molecular sciences Vol. 25; no. 7; p. 3758
• Main Authors: Renna, Felipe J, Gonzalez, Claudio D, Vaccaro, Maria I
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.04.2024
• Subjects: Antigens; Autophagy; Autophagy - genetics; Cancer; Cancer therapies; Carcinoma, Hepatocellular; Chemotherapy; Colon cancer; Colonic Neoplasms; Development and progression; Endoplasmic reticulum; Genes; Health aspects; Humans; Kinases; Liver Neoplasms; Mediation; Membrane Proteins; Metabolism; Metastasis; MicroRNAs - genetics; Mutation; Pancreatic cancer; Pancreatitis; Phosphatase; Physiology; Prevention; Proteins; Proteolysis; Sarcoma; Tumorigenesis; Tumors; VMP1; VMP1; cancer; autophagy
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25073758

Autophagy, a catabolic process orchestrating the degradation of proteins and organelles within lysosomes, is pivotal for maintaining cellular homeostasis. However, its dual role in cancer involves preventing malignant transformation while fostering progression and therapy resistance. Vacuole Membrane Protein 1 (VMP1) is an essential autophagic protein whose expression, per se, triggers autophagy, being present in the whole autophagic flux. In pancreatic cancer, VMP1-whose expression is linked to the Kirsten Rat Sarcoma Virus (KRAS) oncogene-significantly contributes to disease promotion, progression, and chemotherapy resistance. This investigation extends to breast cancer, colon cancer, hepatocellular carcinoma, and more, highlighting VMP1's nuanced nature, contingent on specific tissue contexts. The examination of VMP1's interactions with micro-ribonucleic acids (miRNAs), including miR-21, miR-210, and miR-124, enhances our understanding of its regulatory network in cancer. Additionally, this article discusses VMP1 gene fusions, especially with ribosomal protein S6 kinase B1 (RPS6KB1), shedding light on potential implications for tumor malignancy. By deciphering the molecular mechanisms linking VMP1 to cancer progression, this exploration paves the way for innovative therapeutic strategies to disrupt these pathways and potentially improve treatment outcomes.